News & Analysis on Clinical Trial Services & Contract Research And Development
Nanogen introduces its latest enterovirus reagent, which employs hybridisation technology designed to detect enteroviruses-associated sequences. Enterovirus infections cause a wide spectrum of diseases and are the most common cause of aseptic meningitis.
A vaccine that has been developed for Alzheimer's disease, which targets the DNA, without any side effects, has produced promising results in mice.
According to a new report, key trends that are occurring within pharma-biotech alliances, as well as within biotech-biotech alliances, are having to grapple with safety concerns and efficacy, which have made biotech a high-risk area for investment.